Transcosmos targets 2040 pharmacist shortage with new partnership
TOKYO, JAPAN — Japanese BPO firm transcosmos is tackling Japan’s looming pharmacist shortage, set to peak by 2040, through a new partnership with the Tokyo University of Pharmacy and Life Sciences (TUPLS).
The collaboration, dubbed the “Partnership Agreement on Promoting Pharmacist Operational Transformation to Address the 2040 Problem,” aims to modernize pharmacy operations using digital transformation and business process outsourcing (BPO) strategies to ease the anticipated workforce gap.
It marks one of the first times a major BPO operator has moved beyond back-office healthcare functions to redesign frontline clinical workflows.
BPO methodology enters the pharmacy floor
Japan’s “2040 Problem” refers to the anticipated surge in medical demand as the second wave of baby boomers all cross 65, precisely as the domestic workforce continues to contract.
The pressure on community pharmacists is acute: they are being asked to take on expanded clinical responsibilities at the same moment the pipeline of qualified professionals narrows.
As Outsource Accelerator has previously reported, Japan faces a shortage of nearly one million foreign workers alone by 2040, underscoring the structural depth of the problem.
Under the agreement, transcosmos and TUPLS will engage in a cross-industry collaboration, leveraging their respective experience and expertise to resolve challenges in community medical services including labor, resource shortages and conduct research on new services that help streamline pharmacists’ operations.
The partnership also aims to develop educational programs combining pharmaceutical knowledge with digital transformation and BPO expertise, and to develop next-generation talent for the medical field.
The deal is explicitly framed as a cross-industry collaboration between an academic institution and a private-sector company, applying what has previously been a commercial methodology to a public-health challenge.
Satoshi Takayama, Corporate Executive Officer at transcosmos, said the company will apply its digital transformation and BPO expertise to pharmacist operational transformation to help resolve community medical service challenges.
TUPLS President Yoshihiro Mimaki co-signed the official agreement announcement.
Transcosmos ranked #192 in the OA500 2025, Outsource Accelerator’s objective index of the world’s top 500 outsourcing firms.
The Tokyo-headquartered company operates 185 bases across 36 countries, with a track record of applying BPO methodology to disrupted sectors most recently in Japan’s construction industry.
A blueprint for healthcare BPO in an ageing world
The partnership’s most consequential element may be its talent development component. Transcosmos and TUPLS plan to co-develop next-generation workers who combine pharmaceutical expertise with operational and digital skills, a “clinical-BPO hybrid” profile that does not yet formally exist across the industry.
For healthcare systems grappling with workforce shortfalls, this presents an exportable blueprint: embed BPO process-design thinking into clinical training from the outset, rather than retrofitting it later.
The implications stretch well beyond Japan. Healthcare systems in the United States, the United Kingdom, and Australia face structurally similar pressures — ageing patient populations, stretched clinical rosters, and a growing imperative to extract greater productivity from existing staff.
As the global healthcare outsourcing sector continues to expand, the transcosmos-TUPLS model offers early evidence of how BPO firms can reposition themselves as strategic partners in workforce transformation, not merely in administrative cost reduction.
As IT Business Today noted, pharmacists are expected to do more, be more involved locally, and work more efficiently using digital tools simultaneously, a combination the partnership is built directly to enable.
For BPO operators and healthcare systems watching from the sidelines, this agreement signals that the industry’s next growth frontier may lie in clinical workflow redesign.
